Literature DB >> 18548233

Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system.

Cristina Núñez1, M Teresa Castells, M Luisa Laorden, M Victoria Milanés.   

Abstract

Our previous studies have shown that morphine withdrawal increases the hypothalamic-pituitary-adrenocortical axis activity, which is dependent on a hyperactivity of noradrenergic pathways (nucleus tractus solitarius-A(2)) innervating the hypothalamic paraventricular nucleus. The extracellular signal-regulated kinase has been implicated in drug addiction, but its role in activation of paraventricular nucleus and nucleus tractus solitarius during morphine dependence remain poorly understood. We have determined the activation of extracellular signal-regulated kinase during morphine dependence and withdrawal as well as its involvement in morphine withdrawal-induced gene expression. We show that naloxone-induced morphine withdrawal activates extracellular signal-regulated kinases(1/2) and increases c-Fos expression in rat paraventricular nucleus and nucleus tractus solitarius-A(2) neurons. Activated extracellular signal-regulated kinases(1/2) was colocalized with c-Fos in both nuclei, and this response was blocked by SL327, a drug that prevents extracellular signal-regulated kinase activation. In the paraventricular nucleus from morphine-withdrawn rats, the number of neurons expressing CRF was increased. Immunohistochemical study showed a dramatic increase in c-Fos immunoreactivity within CRF-positive cells. These results suggest that extracellular signal-regulated kinases1/2 signaling pathway is necessary for morphine withdrawal-induced activation of brain areas associated with the stress system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18548233     DOI: 10.1007/s00210-008-0304-9

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization.

Authors:  Shoshana Eitan; Camron D Bryant; Nazli Saliminejad; Yu C Yang; Elroy Vojdani; Duane Keith; Roberto Polakiewicz; Christopher J Evans
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

Review 2.  Addiction and the brain antireward system.

Authors:  George F Koob; Michel Le Moal
Journal:  Annu Rev Psychol       Date:  2008       Impact factor: 24.137

Review 3.  Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence.

Authors:  J G Liu; K J Anand
Journal:  Brain Res Brain Res Rev       Date:  2001-12

4.  Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.

Authors:  M L Laorden; M T Castells; M D Martínez; P J Martínez; M V Milanés
Journal:  Endocrinology       Date:  2000-04       Impact factor: 4.736

5.  Isolated removal of hypothalamic or other brain nuclei of the rat.

Authors:  M Palkovits
Journal:  Brain Res       Date:  1973-09-14       Impact factor: 3.252

6.  Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase PIN1.

Authors:  Paula Monje; Javier Hernández-Losa; Ruth J Lyons; Maria D Castellone; J Silvio Gutkind
Journal:  J Biol Chem       Date:  2005-08-25       Impact factor: 5.157

7.  Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.

Authors:  Víctor J Asensio; Antonio Miralles; Jesús A García-Sevilla
Journal:  Eur J Pharmacol       Date:  2006-04-06       Impact factor: 4.432

8.  Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat.

Authors:  L W Swanson; D M Simmons
Journal:  J Comp Neurol       Date:  1989-07-22       Impact factor: 3.215

9.  Multiple signaling pathways in bovine chromaffin cells regulate tyrosine hydroxylase phosphorylation at Ser19, Ser31, and Ser40.

Authors:  J W Haycock
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

10.  Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system.

Authors:  M T Berhow; D S Russell; R Z Terwilliger; D Beitner-Johnson; D W Self; R M Lindsay; E J Nestler
Journal:  Neuroscience       Date:  1995-10       Impact factor: 3.590

View more
  8 in total

1.  Protein kinase C phosphorylates the cAMP response element binding protein in the hypothalamic paraventricular nucleus during morphine withdrawal.

Authors:  F Martín; L Mora; Ml Laorden; Mv Milanés
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

2.  The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats.

Authors:  Shuanglin Hao; Shue Liu; Xuexing Zheng; Wenwen Zheng; Handong Ouyang; Marina Mata; David J Fink
Journal:  Neuropsychopharmacology       Date:  2010-11-10       Impact factor: 7.853

3.  MAP kinases couple hindbrain-derived catecholamine signals to hypothalamic adrenocortical control mechanisms during glycemia-related challenges.

Authors:  Arshad M Khan; Kimberly L Kaminski; Graciela Sanchez-Watts; Todd A Ponzio; J Brent Kuzmiski; Jaideep S Bains; Alan G Watts
Journal:  J Neurosci       Date:  2011-12-14       Impact factor: 6.167

4.  Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal.

Authors:  Cristina Núñez; Anna Földes; Domingo Pérez-Flores; J Carlos García-Borrón; M Luisa Laorden; Krisztina J Kovács; M Victoria Milanés
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

5.  Opioids inhibit visceral afferent activation of catecholamine neurons in the solitary tract nucleus.

Authors:  R J Cui; B L Roberts; H Zhao; M C Andresen; S M Appleyard
Journal:  Neuroscience       Date:  2012-07-13       Impact factor: 3.590

6.  Morphine Withdrawal Modifies Prion Protein Expression in Rat Hippocampus.

Authors:  Vincenzo Mattei; Stefano Martellucci; Francesca Santilli; Valeria Manganelli; Tina Garofalo; Niccolò Candelise; Alessandra Caruso; Maurizio Sorice; Sergio Scaccianoce; Roberta Misasi
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

Review 7.  An emerging new paradigm in opioid withdrawal: a critical role for glia-neuron signaling in the periaqueductal gray.

Authors:  Handong Ouyang; Shue Liu; Weian Zeng; Roy C Levitt; Keith A Candiotti; Shuanglin Hao
Journal:  ScientificWorldJournal       Date:  2012-08-02

8.  Role of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc).

Authors:  Pilar Almela; Javier Navarro-Zaragoza; Juan-Antonio García-Carmona; Lucía Mora; Juana Hidalgo; María-Victoria Milanés; María-Luisa Laorden
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.